{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:01:44Z","timestamp":1789549304144,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04353-x","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:03:46Z","timestamp":1775196226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Biomimetic hybrid nanocarriers hitchhike neutrophils for targeted ginsenoside Rc delivery to BMSCs: ameliorating postmenopausal osteoporosis via iron homeostasis regulation"],"prefix":"10.1186","volume":"24","author":[{"given":"Yi","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depeng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binjie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baosheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"4353_CR1","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S2213-8587(17)30184-5","volume":"5","author":"R Eastell","year":"2017","unstructured":"Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. 2017;5:908\u201323.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4353_CR2","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJMcp2307353","volume":"389","author":"MD Walker","year":"2023","unstructured":"Walker MD, Shane E. Postmenopausal Osteoporosis. N Engl J Med. 2023;389:1979\u201391.","journal-title":"N Engl J Med"},{"key":"4353_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMcp1513724","volume":"374","author":"DM Black","year":"2016","unstructured":"Black DM, Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N Engl J Med. 2016;374:254\u201362.","journal-title":"N Engl J Med"},{"key":"4353_CR4","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","volume":"33","author":"MS LeBoff","year":"2022","unstructured":"LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG, Singer AJ, Siris ES. The clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022;33:2049\u2013102.","journal-title":"Osteoporos Int"},{"key":"4353_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41574-020-0339-7","volume":"16","author":"IR Reid","year":"2020","unstructured":"Reid IR. A broader strategy for osteoporosis interventions. Nat Rev Endocrinol. 2020;16:333\u20139.","journal-title":"Nat Rev Endocrinol"},{"key":"4353_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102626","volume":"52","author":"G Shen","year":"2020","unstructured":"Shen G, Ren H, Shang Q, Zhao W, Zhang Z, Yu X, et al. Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt\/beta-catenin signalling pathway and prevents ovariectomy-induced bone loss. EBioMedicine. 2020;52:102626.","journal-title":"EBioMedicine"},{"key":"4353_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.freeradbiomed.2024.08.014","volume":"223","author":"D Li","year":"2024","unstructured":"Li D, Zhao Z, Zhu L, Feng H, Song J, Fu J, Li J, Chen Z, Fu H. 7,8-DHF inhibits BMSC oxidative stress via the TRKB\/PI3K\/AKT\/NRF2 pathway to improve symptoms of postmenopausal osteoporosis. Free Radic Biol Med. 2024;223:413\u201329.","journal-title":"Free Radic Biol Med"},{"key":"4353_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-025-01543-2","author":"L Zhang","year":"2025","unstructured":"Zhang L, Qi B, Li Y, Liang X, Zhang Z, Yang T, et al. GLUL mediates FOXO3 O-GlcNAcylation to regulate the osteogenic differentiation of BMSCs and senile osteoporosis. Cell Death Differ. 2025. https:\/\/doi.org\/10.1038\/s41418-025-01543-2.","journal-title":"Cell Death Differ"},{"key":"4353_CR9","doi-asserted-by":"publisher","first-page":"e111762","DOI":"10.15252\/embj.2022111762","volume":"42","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, Cai GP, Feng X, Li YJ, Guo WH, Guo Q, Huang Y, Su T, Li CJ, Luo XH, et al. Splicing factor YBX1 regulates bone marrow stromal cell fate during aging. EMBO J. 2023;42:e111762.","journal-title":"EMBO J"},{"key":"4353_CR10","first-page":"336","volume":"41","author":"Y Yang","year":"2024","unstructured":"Yang Y, Zhang X, Gao P, Fan W, Zheng T, Yang W, Tang Y, Cai K. A two-pronged approach to inhibit ferroptosis of MSCs caused by the iron overload in postmenopausal osteoporosis and promote osseointegration of titanium implant. Bioact Mater. 2024;41:336\u201354.","journal-title":"Bioact Mater"},{"key":"4353_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4353_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-025-02268-7","author":"Y Li","year":"2025","unstructured":"Li Y, Li P, Yang L, Li H. 4-Octyl Itaconate Attenuates Postmenopausal Osteoporosis by Inhibiting Ferroptosis and Enhancing Osteogenesis via the Nrf2 Pathway. Inflammation. 2025. https:\/\/doi.org\/10.1007\/s10753-025-02268-7.","journal-title":"Inflammation"},{"key":"4353_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70288","volume":"29","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Sun R, Yang H, Gu T, Han M, Yu C, et al. Aucubin promotes BMSCs proliferation and differentiation of postmenopausal osteoporosis patients by regulating ferroptosis and BMP2 signalling. J Cell Mol Med. 2025;29:e70288.","journal-title":"J Cell Mol Med"},{"key":"4353_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101501","volume":"31","author":"Y Wang","year":"2025","unstructured":"Wang Y, Sun L, Dong Z, Zhang T, Wang L, Cao Y, et al. Targeted inhibition of ferroptosis in bone marrow mesenchymal stem cells by engineered exosomes alleviates bone loss in smoking-related osteoporosis. Mater Today Bio. 2025;31:101501.","journal-title":"Mater Today Bio"},{"key":"4353_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155284","volume":"124","author":"Z Jiang","year":"2024","unstructured":"Jiang Z, Deng L, Li M, Alonge E, Wang Y. Ginsenoside Rg1 modulates PI3K\/AKT pathway for enhanced osteogenesis via GPER. Phytomedicine. 2024;124:155284.","journal-title":"Phytomedicine"},{"issue":"11","key":"4353_CR16","doi-asserted-by":"publisher","first-page":"5828","DOI":"10.3390\/ijms25115828","volume":"25","author":"SY Ko","year":"2024","unstructured":"Ko SY. Therapeutic Potential of Ginsenosides on Bone Metabolism: A Review of Osteoporosis, Periodontal Disease and Osteoarthritis. Int J Mol Sci. 2024;25(11):5828. https:\/\/doi.org\/10.3390\/ijms25115828.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4353_CR17","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.3390\/nu17111910","volume":"17","author":"SH Park","year":"2025","unstructured":"Park SH. Recent Research on the Role of Phytochemicals from Ginseng in Management of Osteosarcoma, Osteoporosis, and Osteoarthritis. Nutrients. 2025;17(11):1910. https:\/\/doi.org\/10.3390\/nu17111910.","journal-title":"Nutrients"},{"issue":"11","key":"4353_CR18","doi-asserted-by":"publisher","first-page":"6187","DOI":"10.3390\/ijms23116187","volume":"23","author":"N Yang","year":"2022","unstructured":"Yang N, Zhang X, Li L, Xu T, Li M, Zhao Q, et al. Ginsenoside Rc Promotes Bone Formation in Ovariectomy-Induced Osteoporosis In Vivo and Osteogenic Differentiation In Vitro. Int J Mol Sci. 2022;23(11):6187. https:\/\/doi.org\/10.3390\/ijms23116187.","journal-title":"Int J Mol Sci"},{"key":"4353_CR19","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1021\/jacs.0c10836","volume":"143","author":"Q Huang","year":"2021","unstructured":"Huang Q, Su H, Qi B, Wang Y, Yan K, Wang X, et al. A SIRT1 activator, ginsenoside Rc, promotes energy metabolism in cardiomyocytes and neurons. J Am Chem Soc. 2021;143:1416\u201327.","journal-title":"J Am Chem Soc"},{"key":"4353_CR20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s12272-013-0223-2","volume":"37","author":"DH Kim","year":"2014","unstructured":"Kim DH, Park CH, Park D, Choi YJ, Park MH, Chung KW, Kim SR, Lee JS, Chung HY. Ginsenoside Rc modulates Akt\/FoxO1 pathways and suppresses oxidative stress. Arch Pharm Res. 2014;37:813\u201320.","journal-title":"Arch Pharm Res"},{"issue":"8","key":"4353_CR21","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3390\/antiox12081576","volume":"12","author":"A Kim","year":"2023","unstructured":"Kim A, Park SM, Kim NS, Lee H. Ginsenoside Rc, an Active Component of Panax ginseng, Alleviates Oxidative Stress-Induced Muscle Atrophy via Improvement of Mitochondrial Biogenesis. Antioxidants. 2023;12(8):1576. https:\/\/doi.org\/10.3390\/antiox12081576.","journal-title":"Antioxidants"},{"key":"4353_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF03179932","volume":"26","author":"YJ Lee","year":"2003","unstructured":"Lee YJ, Jin YR, Lim WC, Ji SM, Cho JY, Ban JJ, Lee SK. Ginsenoside Rc and Re stimulate c-fos expression in MCF-7 human breast carcinoma cells. Arch Pharm Res. 2003;26:53\u20137.","journal-title":"Arch Pharm Res"},{"key":"4353_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jgr.2016.02.001","volume":"41","author":"T Yu","year":"2017","unstructured":"Yu T, Yang Y, Kwak YS, Song GG, Kim MY, Rhee MH, et al. Ginsenoside rc from Panax ginseng exerts anti-inflammatory activity by targeting TANK-binding kinase 1\/interferon regulatory factor-3 and p38\/ATF-2. J Ginseng Res. 2017;41:127\u201333.","journal-title":"J Ginseng Res"},{"key":"4353_CR24","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.jpha.2023.08.013","volume":"13","author":"Z Lu","year":"2023","unstructured":"Lu Z, Mao T, Chen K, Chai L, Dai Y, Liu K. Ginsenoside rc: a potential intervention agent for metabolic syndrome. J Pharm Anal. 2023;13:1375\u201387.","journal-title":"J Pharm Anal"},{"key":"4353_CR25","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41565-023-01374-7","volume":"18","author":"Z Luo","year":"2023","unstructured":"Luo Z, Lu Y, Shi Y, Jiang M, Shan X, Li X, et al. Neutrophil hitchhiking for drug delivery to the bone marrow. Nat Nanotechnol. 2023;18:647\u201356.","journal-title":"Nat Nanotechnol"},{"key":"4353_CR26","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/s41467-020-14963-0","volume":"11","author":"M Li","year":"2020","unstructured":"Li M, Li S, Zhou H, Tang X, Wu Y, Jiang W, Tian Z, Zhou X, Yang X, Wang Y. Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy. Nat Commun. 2020;11:1126.","journal-title":"Nat Commun"},{"key":"4353_CR27","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1021\/acsami.2c18244","volume":"15","author":"XZ Liu","year":"2023","unstructured":"Liu XZ, Wen ZJ, Li YM, Sun WR, Hu XQ, Zhu JZ, et al. Bioengineered bacterial membrane vesicles with multifunctional nanoparticles as a versatile platform for cancer immunotherapy. ACS Appl Mater Interfaces. 2023;15:3744\u201359.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4353_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jconrel.2023.09.037","volume":"363","author":"W Meng","year":"2023","unstructured":"Meng W, Wang L, Du X, Xie M, Yang F, Li F, et al. Engineered mesenchymal stem cell-derived extracellular vesicles constitute a versatile platform for targeted drug delivery. J Control Release. 2023;363:235\u201352.","journal-title":"J Control Release"},{"key":"4353_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-024-00325-9","volume":"12","author":"D Wang","year":"2024","unstructured":"Wang D, Guo Y, Heng BC, Zhang X, Wei Y, He Y, et al. Cell membrane vesicles derived from hBMSCs and hUVECs enhance bone regeneration. Bone Res. 2024;12:23.","journal-title":"Bone Res"},{"key":"4353_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.961903","volume":"13","author":"A Wang","year":"2022","unstructured":"Wang A, Zhang H, Li G, Chen B, Li J, Zhang T, et al. Deciphering core proteins of osteoporosis with iron accumulation by proteomics in human bone. Front Endocrinol (Lausanne). 2022;13:961903.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4353_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s11596-023-2764-z","volume":"43","author":"GF Li","year":"2023","unstructured":"Li GF, Gao Y, Weinberg ED, Huang X, Xu YJ. Role of iron accumulation in osteoporosis and the underlying mechanisms. Curr Med Sci. 2023;43:647\u201354.","journal-title":"Curr Med Sci"},{"key":"4353_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jchromb.2012.12.022","volume":"919\u2013920","author":"Y Chu","year":"2013","unstructured":"Chu Y, Zhang HC, Li SM, Wang JM, Wang XY, Li W, Zhang LL, Ma XH, Zhou SP, Zhu YH, Liu CX. Determination of ginsenoside Rc in rat plasma by LC-MS\/MS and its application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;919\u2013920:75\u20138.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"4353_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4488822","volume":"2021","author":"LY Du","year":"2021","unstructured":"Du LY, Jiang T, Wei K, Zhu S, Shen YL, Ye P, et al. Simultaneous quantification of four ginsenosides in rat plasma and its application to a comparative pharmacokinetic study in normal and depression rats using UHPLC-MS\/MS. J Anal Methods Chem. 2021;2021:4488822.","journal-title":"J Anal Methods Chem"},{"key":"4353_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2025.156147","volume":"165","author":"J Chen","year":"2025","unstructured":"Chen J, Liao Y, Sheng Y, Yao H, Li T, He Z, et al. FSH exacerbates bone loss by promoting osteoclast energy metabolism through the CREB-MDH2-NAD(+) axis. Metabolism. 2025;165:156147.","journal-title":"Metabolism"},{"key":"4353_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156205","volume":"135","author":"Q Ma","year":"2024","unstructured":"Ma Q, Xiong Y, Jie Z, Li C, Wang C, Cai J, et al. Damascenone inhibits osteoclastogenesis by epigenetically modulating Nrf2-mediated ROS scavenge and counteracts OVX-induced osteoporosis. Phytomedicine. 2024;135:156205.","journal-title":"Phytomedicine"},{"key":"4353_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156297","volume":"136","author":"F Wang","year":"2025","unstructured":"Wang F, Zhang F, Lin B, Xiao W, Wang X, Wang N. Sarsasapogenin stimulates angiogenesis and osteogenesis coupling to treat estrogen deficiency-induced osteoporosis by activating the GPX4\/SLIT3\/ROBO1 axis. Phytomedicine. 2025;136:156297.","journal-title":"Phytomedicine"},{"key":"4353_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102711","volume":"63","author":"Z Zhong","year":"2023","unstructured":"Zhong Z, Zhang C, Ni S, Ma M, Zhang X, Sang W, et al. NFATc1-mediated expression of SLC7A11 drives sensitivity to TXNRD1 inhibitors in osteoclast precursors. Redox Biol. 2023;63:102711.","journal-title":"Redox Biol"},{"key":"4353_CR38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2423991122","volume":"122","author":"X Mo","year":"2025","unstructured":"Mo X, Meng K, Xu B, Li Z, Lan S, Ren Z, et al. Nat10-mediated N4-acetylcytidine modification enhances Nfatc1 translation to exacerbate osteoclastogenesis in postmenopausal osteoporosis. Proc Natl Acad Sci U S A. 2025;122:e2423991122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4353_CR39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jare.2024.01.003","volume":"66","author":"W Fan","year":"2024","unstructured":"Fan W, Fan L, Wang Z, Mei Y, Liu L, Li L, et al. Rare ginsenosides: a unique perspective of ginseng research. J Adv Res. 2024;66:303\u201328.","journal-title":"J Adv Res"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04353-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04353-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04353-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:58:14Z","timestamp":1778713094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04353-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4353"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04353-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"439"}}